• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.

出版信息

Clin Adv Hematol Oncol. 2007 Feb;5(2):79-81.

PMID:17344795
Abstract
摘要

相似文献

1
RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas.RTOG 0522：一项针对III期和IV期头颈癌的随机III期试验，比较同步加速放疗和顺铂与同步加速放疗、顺铂和西妥昔单抗（随后为部分患者进行手术）的疗效。
Clin Adv Hematol Oncol. 2007 Feb;5(2):79-81.
2
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.贝伐珠单抗联合顺铂和调强放疗治疗 III/IVB 期头颈部鳞状细胞癌的 II 期研究。
Cancer. 2012 Oct 15;118(20):5008-14. doi: 10.1002/cncr.27498. Epub 2012 Mar 13.
3
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.西妥昔单抗、顺铂与同期增量放疗联合治疗局部晚期头颈部鳞状细胞癌：一种新型联合治疗模式的II期初步研究
J Clin Oncol. 2006 Mar 1;24(7):1072-8. doi: 10.1200/JCO.2004.00.1792.
4
Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.毒性治疗：社区中针对Ⅲ期和ⅣA期头颈癌采用超分割放疗联合顺铂和氟尿嘧啶治疗
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):698-704. doi: 10.1016/S0360-3016(03)01576-1.
5
Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.局部晚期头颈部癌同步氟尿嘧啶、羟基脲、西妥昔单抗和超分割调强放疗的 2 期临床试验。
Cancer. 2011 Jan 15;117(2):318-26. doi: 10.1002/cncr.25374. Epub 2010 Sep 9.
6
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.放射肿瘤学组97-03的初步结果：一项关于晚期头颈部鳞状细胞癌同步放化疗的随机II期试验。
J Clin Oncol. 2004 Jul 15;22(14):2856-64. doi: 10.1200/JCO.2004.12.012.
7
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.头颈部高危鳞状细胞癌的术后放化疗及西妥昔单抗治疗：放射肿瘤学组RTOG-0234
J Clin Oncol. 2014 Aug 10;32(23):2486-95. doi: 10.1200/JCO.2013.53.9163. Epub 2014 Jul 7.
8
Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).局部晚期头颈部鳞状细胞癌（SCCHN）患者中，超分割放疗与传统分割放疗联合多西他赛、顺铂和5-氟尿嘧啶（TPF）同步化疗的比较。
Cancer Chemother Pharmacol. 2007 Aug;60(3):399-406. doi: 10.1007/s00280-006-0370-y. Epub 2006 Nov 10.
9
Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis.西妥昔单抗、紫杉醇、卡铂联合放疗治疗头颈部肿瘤：毒性分析。
Am J Clin Oncol. 2010 Apr;33(2):144-7. doi: 10.1097/COC.0b013e3181979093.
10
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.头颈部未切除局部晚期鳞状细胞癌超分割与加速放疗及放化疗联合方案的荟萃分析
BMC Cancer. 2006 Jan 31;6:28. doi: 10.1186/1471-2407-6-28.

引用本文的文献

1
A comparison of two methodologies for radiotherapy treatment plan optimization and QA for clinical trials.两种用于临床试验放射治疗计划优化和 QA 的方法比较。
J Appl Clin Med Phys. 2021 Oct;22(10):329-337. doi: 10.1002/acm2.13401. Epub 2021 Aug 25.
2
The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment.临床试验质量保证对头颈部放射治疗结果的影响
Front Oncol. 2019 Aug 21;9:792. doi: 10.3389/fonc.2019.00792. eCollection 2019.
3
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
口咽癌患者总生存和无进展生存预测列线图的开发与验证
J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.
4
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.口腔和口咽癌的治疗干预措施：靶向治疗和免疫治疗。
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010341. doi: 10.1002/14651858.CD010341.pub2.
5
Chemotherapy advances in locally advanced head and neck cancer.局部晚期头颈癌的化疗进展
World J Clin Oncol. 2014 Dec 10;5(5):966-72. doi: 10.5306/wjco.v5.i5.966.
6
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.西妥昔单抗联合顺铂及放疗用于不可切除的局部晚期头颈部鳞状细胞癌的II期研究：东部肿瘤协作组试验E3303
Clin Cancer Res. 2014 Oct 1;20(19):5041-51. doi: 10.1158/1078-0432.CCR-14-0051. Epub 2014 Aug 8.
7
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.人乳头瘤病毒与口咽鳞状细胞癌进展后的总生存期
J Clin Oncol. 2014 Oct 20;32(30):3365-73. doi: 10.1200/JCO.2014.55.1937. Epub 2014 Jun 23.
8
Vision 20/20: perspectives on automated image segmentation for radiotherapy.《视力20/20：放射治疗自动图像分割的前景》
Med Phys. 2014 May;41(5):050902. doi: 10.1118/1.4871620.
9
Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.表皮生长因子受体抑制剂引起的滤泡炎，四环素在管理中的预防和治疗效果，以及根据所使用的表皮生长因子受体抑制剂的类型的发生率：系统文献回顾。
Oncologist. 2012;17(4):555-68. doi: 10.1634/theoncologist.2011-0365. Epub 2012 Mar 16.
10
Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).三种现代联合器官保存方案治疗局部晚期头颈部鳞状细胞癌（SCCHN）的疾病控制和功能结局。
Radiat Oncol. 2011 Sep 23;6:122. doi: 10.1186/1748-717X-6-122.